作者: Nathan Lawrentschuk , Masoom A. Haider , Nikhil Daljeet , Andrew Evans , Ants Toi
DOI: 10.1111/J.1464-410X.2009.08938.X
关键词:
摘要: OBJECTIVE To review our experience and delineate the role of magnetic resonance imaging (MRI) in identifying patients presenting with a raised prostate-specific antigen (PSA) level clinical findings suggestive anterior predominant tumours, which appear to be significant, particularly those previous negative biopsy or low-volume disease undergoing active surveillance. PATIENTS AND METHODS We retrospectively reviewed database identify anteriorly tumours on MRI whom had undergone prostate biopsy. RESULTS In all, 31 also positive (14 surveillance 17 biopsies). was usually invoked by PSA velocity. predictive value for 87% (27/31). The Gleason score distribution 27 men cancer 6 15; 3 + 4 three, six 8/9 three. For prostatic cores, 44/85 (52%) samples from cancer. Thirteen radical prostatectomy (pT2 pT3 seven pT4 three); 13 surgical margins third them biochemical recurrence at 1-year follow-up. CONCLUSION There is subset either having who are should considered further biopsy, as their pathology might aggressive. An entity emerging that impalpable, we believe term 'prostate evasive tumour syndrome' appropriate. This requires analysis large prospective consideration triggers targeted biopsies.